Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2016

Feb 17, 2016

30016_dirs_2016-02-17_00000543-1fb3-47c0-84e1-e359e9893e0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-12-31

Reporting Person: SZOSTAK M ANNE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-14 Common Stock J 13416 $0.00 Disposed 584 Direct
2015-12-14 Common Stock J 13416 $0.00 Acquired 13416 Indirect
2015-12-14 Common Stock G 6816 $0.00 Disposed 6600 Indirect
2015-12-14 Common Stock G 6816 $0.00 Acquired 6816 Indirect

Footnotes

F1: The character of the reporting person's ownership interest in the shares of Issuer common stock are being reclassified from direct to indirect. These shares have been transferred to the 2014 Szostak IDEXX GRAT (the "GRAT") over time. The reporting person is the settlor and trustee of the GRAT. The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest in the GRAT.

F2: These shares have been transferred from the GRAT to the M. Anne Szostak Trust (the "Trust"). The reporting person is the settlor of the Trust, the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.